NCT07218913 2026-04-17
Testing the Addition of Pedmark to Cisplatin Chemotherapy for Reducing Drug-Induced Ear Damage in Men With Stage II-III Metastatic Testicular Germ Cell Tumors
City of Hope Medical Center
Phase 1 Recruiting
Clinical Trials
13 trialsNCT06517888 2026-04-06
Anti-VEGF Gene Therapy Trial for Vestibular Schwannoma
Akouos, Inc.
Phase 1/2 Recruiting
NCT04915183 2026-03-09
Atorvastatin to Reduce Cisplatin-Induced Hearing Loss Among Individuals With Head and Neck Cancer
National Institutes of Health Clinical Center (CC)
Phase 2 Recruiting
NCT07420751 2026-02-20
Assessment of Patient Experience With Auto-Captioning Glasses in NF2-Related-Schwannomatosis
Massachusetts General Hospital
Phase NA Recruiting
NCT06781749 2026-01-13
New Approach to Objectively Measure Social Engagement in Older Adults With Hearing Loss
University of Southern California
Recruiting
NCT05582551 2025-12-22
Patients At Risk for Sensory Screening (HPARSS) to Enhance Sensory Deficit Screening in Childhood Cancer Survivors
Washington University School of Medicine
Phase NA Recruiting
NCT06303180 2025-11-14
NIDCD Otolaryngology Clinical Protocol Biospecimen Bank
National Institutes of Health Clinical Center (CC)
Recruiting
NCT02310399 2025-10-30
Auditory Brainstem Implant (ABI) in Children With No Cochleae or Auditory Nerves
NYU Langone Health
Phase NA Recruiting
NCT06551857 2025-04-16
CaSPiN
Turku University Hospital
Recruiting
NCT05641441 2025-01-13
Radiosurgery Induced Ototoxicity in Patients Treated for a Vestibular Schwannoma
University Hospital, Geneva
Recruiting
NCT03745534 2024-11-25
Cochlear Implantation After Gamma Knife Radiosurgery with EABR and Correlation to Postoperative Hearing Results - a Pilot Study
Medical University of Vienna
Recruiting
NCT03745560 2024-11-25
Intraoperative EABR for Decision Making
Medical University of Vienna
Recruiting
NCT03914378 2024-05-08
EARAD
University of Manchester
Recruiting